IP Library Granted Patent US 10,131,634
Granted Patent B2
US 10,131,634 · App. 14/303,711 · Granted Nov 20, 2018

Method of treating pain

Inventors: Eric M. Ostertag (Lexington, KY); John Stuart Crawford (Lexington, KY)
Assignee: Poseida Therapeutics, Inc.
C07D215/38A61K31/00A61K31/4709A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,131,634
App. No.
14/303,711
Granted
Nov 20, 2018
Kind
B2
Abstract

The instant application discloses methods of treating, reducing, or preventing pain in a mammal, which may include administering a compound capable of modulating a transient receptor potential channel. In one aspect, the TRP channel may be TRPC4. Types of pain contemplated by the present disclosure include acute, chronic, neuropathic, and nociceptive pain.

Claims (3)

1. A method of treating, reducing, or preventing pain in a mammal, comprising administering a therapeutically effective amount of a composition to a human in need thereof, said composition comprising 4-methyl-2-piperidin-1-yl-quinoline having the formula

wherein said compound is administered orally, wherein the composition is capable of modulating Trpc4 activity to alleviate pain, wherein the pain is visceral.

2. The method of claim 1 , wherein said composition further comprises one or more additional pharmaceutically active agents selected from non-opioid analgesics, opioid analgesics, anti-epileptics, NMDA antagonists, lidocaine, tricyclic antidepressants, and a combination thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2015
From: TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
To: POSEIDA THERAPEUTICS, INC.
Reel/Frame 035537/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2014
From: OSTERTAG, ERIC M.; CRAWFORD, JOHN STUART
To: TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
Reel/Frame 033097/0022 →
Continuity (3)
Continuation PCTUS2012069753 · Dec 14, 2012
Provisional Application 61576619 · Dec 16, 2011
Related Publication 20140329856A1 · Nov 6, 2014